What we produce

Developing and manufacturing life-saving products

 

We are the first and only manufacturers of Erwinase® (Crisantaspase) an asparginase enzyme indicated for the treatment of Acute Lymphoblastic Leukaemia and of the UK’s licensed anthrax vaccine.

Erwinase

Erwinase

Porton Biopharma is the sole manufacturer of Erwinase® (Crisantaspase) used in the treatment of Acute Lymphoblastic Leukaemia which is distributed and marketed on a world-wide basis by Clinigen Inc. The product is manufactured in our licensed cGMP pharmaceutical manufacturing facilities.

For members of the public
For health professionals

Anthrax Vaccine

Porton Biopharma is the sole manufacturer of the UK’s licensed anthrax vaccine. The vaccine is manufactured for, and on behalf of, the UK Government. It is supplied for both occupational health purposes and to protect those at risk from the use of anthrax as a biological weapon.

For members of the public
For health professionals

Become part of the team

If you are a motivated person who is interested in working in a high-tech environment as part of a dynamic team, then there could be a role for you.

More about us

Registered in England and Wales, company number 9331560. Registered office at Manor Farm Road, Porton Down, Salisbury, Wiltshire SP4 0JG. VAT number is GB 206 6518 18.